Clinical Scorecard: Assessment of the Safety and Effectiveness of the Transoral Endoscopic Thyroidectomy Vestibular Technique for Papillary Thyroid Carcinoma: A Network Meta-Analysis

At a Glance

Key Highlights

• TOETVA offers comparable surgical outcomes to OT and ABA with better parathyroid protection.
• OT and ABA have shorter operative times compared to TOETVA.
• No significant differences in tumor radicality or nerve injury among the three approaches.
• TOETVA is superior to OT in preventing temporary hypoparathyroidism.
• All approaches demonstrated safe and reliable clinical efficacy for PTC.

Guideline-Based Recommendations

Diagnosis

• Diagnosis of papillary thyroid carcinoma should be confirmed through histopathological examination.

Management

• Surgical resection remains the primary treatment for papillary thyroid carcinoma.

Monitoring & Follow-up

• Postoperative monitoring for complications such as nerve injury and hypoparathyroidism is recommended.

Risks

• Potential risks include temporary or permanent recurrent laryngeal nerve injury and hypoparathyroidism.

Patient & Prescribing Data

Patients with papillary thyroid carcinoma undergoing thyroidectomy.

TOETVA is a feasible alternative to traditional open thyroidectomy, offering aesthetic benefits.

Clinical Best Practices

• Consider TOETVA for patients seeking minimally invasive options with good cosmetic outcomes.
• Evaluate individual patient factors when selecting surgical approach.

Related Resources & Content

• Network Meta-Analysis